Benjamin F. Edwards & Company’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$4K Sell
162
-285
-64% -$8.09K ﹤0.01% 1908
2024
Q1
$15K Sell
447
-16
-3% -$545 ﹤0.01% 1597
2023
Q4
$17K Buy
+463
New +$15.9K ﹤0.01% 1517
2020
Q2
Sell
-2
Closed 1659
2020
Q1
$0 Hold
2
﹤0.01% 1700
2019
Q4
$0 Hold
2
﹤0.01% 1856
2019
Q3
$0 Sell
2
-138
-99% -$3.15K ﹤0.01% 1824
2019
Q2
$3K Sell
140
-452
-76% -$9.3K ﹤0.01% 1719
2019
Q1
$8K Sell
592
-8
-1% -$140 ﹤0.01% 1365
2018
Q4
$9K Sell
600
-234
-28% -$6.05K ﹤0.01% 1302
2018
Q3
$33K Sell
834
-89
-10% -$4.01K ﹤0.01% 965
2018
Q2
$45K Sell
923
-512
-36% -$29K ﹤0.01% 874
2018
Q1
$86K Sell
1,435
-73
-5% -$4.87K 0.01% 716
2017
Q4
$119K Sell
1,508
-11
-0.7% -$887 0.01% 609
2017
Q3
$128K Sell
1,519
-8
-0.5% -$567 0.02% 551
2017
Q2
$100K Sell
1,527
-13
-0.8% -$884 0.01% 569
2017
Q1
$112K Sell
1,540
-16
-1% -$1.05K 0.02% 533
2016
Q4
$91K Buy
+1,556
New +$82.1K 0.01% 517

Other funds holding ADNT

Benjamin F. Edwards & Company's ADNT Position: Q2 2024 in Review

Benjamin F. Edwards & Company reduced its Adient (ADNT) stake by 64% in Q2 2024, selling an estimated $8.09K and leaving 162 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #1908.

Benjamin F. Edwards & Company first reported a position in ADNT in Q4 2016 and has held it in 17 quarters since. The position peaked at $128K in Q3 2017. 279 funds tracked by Wall St. Rank hold ADNT as of Q2 2024.

  • Benjamin F. Edwards & Company held 162 shares of Adient worth $4K as of Q2 2024.
  • Benjamin F. Edwards & Company sold 285 Adient shares in Q2 2024, an estimated $8.09K.
  • Adient made up ﹤0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #1908 holding.
  • Benjamin F. Edwards & Company first reported a position in Adient in Q4 2016 and has held it in 17 quarters since.
  • Benjamin F. Edwards & Company's Adient position peaked at $128K in Q3 2017.
  • 279 funds tracked by Wall St. Rank held Adient as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.